循环Activin A与肾脏纤维化及不良事件的关系
在339例经肾活检确诊肾脏疾病的患者中,血浆Activin A水平与肾小管间质纤维化程度显著相关,肾脏INHBA表达与血浆Activin A水平正相关,肌成纤维细胞是病变肾脏中主要的Activin A阳性间质细胞。中位随访22个月期间113例发生主要不良肾脏事件,Cox分析初始发现血浆Activin A水平与肾脏事件风险正相关,但校正混杂因素后变得不显著。体外实验显示敲低Activin A可显著减弱TGF-β诱导的成纤维细胞-肌成纤维细胞转化。
要点
- 血浆Activin A水平与肾小管间质纤维化程度显著相关。
- 肾脏INHBA表达与血浆Activin A水平呈正相关。
- 血浆Activin A与肾脏事件风险的关联在校正混杂后不显著。
核心结论
- 血浆Activin A水平与多种肾脏疾病的肾脏纤维化严重程度及不良结局相关。
研究设计与样本
- 在三级医疗中心对接受原生肾活检的患者进行的研究,共纳入339例经活检确诊肾脏疾病的患者,基线eGFR为36 ml/min per 1.73 m²,尿蛋白/肌酐比为2.9 mg/mg。
- 对肾脏活检标本进行RNA测序和组织学分析以评估Activin A表达,并进行体外实验探索通过抑制Activin A减弱TGF-β诱导的成纤维细胞活化。
主要发现
- 多变量logistic回归分析显示血浆Activin A水平与肾小管间质纤维化程度显著相关。
- RNA测序数据显示肾脏INHBA表达与血浆Activin A水平呈正相关。
- 组织学分析显示肌成纤维细胞是病变肾脏中主要的Activin A阳性间质细胞。
- 中位随访22个月期间,113例参与者发生主要不良肾脏事件;Cox比例风险分析初始发现血浆Activin A水平与肾脏事件风险正相关,但校正混杂因素后变得不显著。
- 在培养的成纤维细胞中,敲低Activin A显著减弱TGF-β诱导的成纤维细胞-肌成纤维细胞转化。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Identification of reliable biomarkers to assess kidney fibrosis severity is necessary for patients with CKD. Activin A, a member of the TGF- β superfamily, has been suggested as a biomarker for kidney fibrosis. However, its precise utility in this regard remains to be established. METHODS: We investigated the correlation between plasma activin A levels, kidney fibrosis severity, and the incidence of major adverse kidney events in patients who underwent native kidney biopsies at a tertiary medical center. We performed RNA sequencing and histological analyses on kidney biopsy specimens to assess activin A expression. In vitro experiments were also conducted to explore the potential attenuation of TGF- β -induced fibroblast activation through activin A inhibition. RESULTS: A total of 339 patients with biopsy-confirmed kidney diseases were enrolled. Baseline eGFR was 36 ml/min per 1.73 m 2 , and the urine protein/creatinine ratio was 2.9 mg/mg. Multivariable logistic regression analysis revealed a significant association between plasma activin A levels and the extent of tubulointerstitial fibrosis. Our RNA sequencing data demonstrated a positive correlation between kidney INHBA expression and plasma activin A levels. Furthermore, the histological analysis showed that myofibroblasts were the primary activin A-positive interstitial cells in diseased kidneys. During a median follow-up of 22 months, 113 participants experienced major adverse kidney events. Cox proportional hazards analysis initially found a positive association between plasma activin A levels and kidney event risk, but it became insignificant after adjusting for confounders. In cultured fibroblasts, knockdown of activin A significantly attenuated TGF- β -induced fibroblast-myofibroblast conversion. CONCLUSIONS: Plasma activin A levels correlate with kidney fibrosis severity and adverse outcomes in various kidney disorders.
引用
- Tsai MT, Ou SM, Lee KH, et al. Circulating Activin A, Kidney Fibrosis, and Adverse Events. Clin J Am Soc Nephrol. 2023. PMID: 37983094. doi:10.2215/CJN.0000000000000365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。